Supportive care for acute disease
Treatment is generally initiated after coordination with occupational health and infectious disease service and<unk> ased the the exposed patient's vaccination history
If the source is<unk> sAg(+) then give<unk> IG x1 and initiate<unk> V vaccine in two separate sites
If source is HGsAG(-) then start the<unk> V vaccine series
If source<unk> lood is unavailable and high risk then give<unk> IG x1 initiate the<unk> V series
If source<unk> lood is low risk and unavailable then<unk> egin<unk> V series
If source<unk> lood is low risk and unavailable then<unk> egin<unk> V series
Non responder status is defined as anti-has <10mIU/mL
If the source is<unk> sAg(+) then give<unk> IG x 1 and<unk> egin revaccination series
Can also opt to perform second<unk> IG administration in one month
If source is<unk> sAg(-) then no treatment is needed
If source<unk> lood is unavailable and high risk then treat as if<unk> sAg(+)
Can also opt to perform second<unk> IG administration in one month
Non responder status is defined as anti-has <10mIU/mL
If the source is<unk> sAg(+) then give<unk> IG x2 and no<unk> V series
If source is HGsAG(-) then no treatment is needed
If source<unk> lood is unavailable then initiate the<unk> V series
No contraindications for pregnancy or<unk> reast feeding<unk> IG 0.06 mL/kg IM
Give in opposite arm from<unk>  vaccine if patient also receiving vaccine
Vaccination series:<unk> V vaccine options:
Engerix-B 20mcg IM
Recombivax<unk>  10mcg IM
Give in opposite arm from<unk>  vaccine if patient also receiving vaccine
Engerix-B 20mcg IM
Recombivax<unk>  10mcg IM
Hepatitis B
Acetaminophen toxicity 
Hepatitis C
Viral hepatitis
Hepatitis D
Hepatitis A
Hepatitis E
Rubella